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The fragmentation characteristics of monohydroxyeicosatetraenoic acids and dihydroxy- and
trihydroxyeicosatrienoic acids were investigated by electrospray ionization Fourier transform
ion cyclotron resonance (FTICR) mass spectrometry using sustained off-resonance irradiation
collision-induced dissociation (SORI-CID) and infrared multiphoton dissociation (IRMPD).
The fragmentation patterns of these compounds were associated with the number and
positions of the hydroxyl substituents. The fragmentation is more complicated with increasing
number of the hydroxyl groups of the compounds. In general, the major carbon–carbon
cleavage of [M  H] ions occurred at the -position to the hydroxyl group, and the
carbon–carbon cleavage occurred when there was a double-bond at the -position to the
hydroxyl group. SORI-CID and IRMPD produced some common fragmentation patterns;
however, each technique provided some unique patterns that are useful for structural
identification of these compounds. This study demonstrated the application of FTICR via the
identification of regioisomers of trihydroxyeicosatrienoic acids in rabbit aorta samples. (J Am
Soc Mass Spectrom 2008, 19, 569–585) © 2008 American Society for Mass SpectrometryMass spectrometry has emerged as an impor-tant tool for analysis of biomolecules. Fouriertransform ion cyclotron resonance (FTICR)
mass spectrometry is one of the techniques that can
provide high mass accuracy and high mass resolution
[1–6]. Accurate molecular weight, elemental composi-
tion, and structural information can be achieved from
FTICR. Sustained off-resonance irradiation collision-
induced dissociation (SORI-CID) and infrared mul-
tiphoton dissociation (IRMPD) are two different disso-
ciation techniques often used with FTICR for MS/MS
analysis. SORI-CID involves collision of the target ion
slightly off its resonance frequency with a collision gas,
causing the acceleration and deceleration of ions during
the RF pulse. At a frequency of several kilohertz,
multiple low-energy collisions occur as ions are vibra-
tionally excited for a sustained period. Unlike SORI-
CID, no collision gas is required for IRMPD. Instead, the
75 W CO2 laser is used to irradiate the ions to form
fragments. The fragments may continue to acquire
some energy from the infrared laser pulse and further
fragment to ions of lower masses. This study demon-
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doi:10.1016/j.jasms.2008.01.007strates the utility of SORI-CID and IRMPD for the
structural characterization of monohydroxyeicosatet-
raenoic acids (HETEs) and dihydroxy- and trihy-
droxyeicosatrienoic acids (DHETs and THETAs).
HETEs, DHETs, and THETAs are metabolites of
arachidonic acid (AA). Different isoforms of lipoxyge-
nases (LOX) metabolize AA to regioisomeric HETEs.
12-Hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE)
and 15-HETE are important lipid mediators in inflam-
mation, kidney, immune system, prostate diseases, and
diabetes [7–14]. Cytochrome P450 epoxygenases metab-
olize AA to 4 regioisomeric epoxyeicosatrienoic acids
(EETs), and soluble epoxide hydrolase (sEH) enzymes
subsequently convert EETs to the corresponding
DHETs [15–17]. EETs have various biological functions,
including inhibiting the hydro-osmotic action of argi-
nine vasopressin in the kidney, calcium mobilization,
and prostaglandin formation [18, 19]. EETs stimulate
relaxation in coronary rings and coronary arterioles
[20–25]. A recent study showed that 14,15-DHET is a
potent peroxisome proliferator-activated receptor-
(PPAR) activator in COS-7 cells [26].
THETAs are new members of the family of
endothelium-derived relaxing factors [27–31]. 11,12,15-
THETA and 11,14,15-THETA were identified as
endothelium-derived lipoxygenase metabolites of AA in
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570 CUI ET AL. J Am Soc Mass Spectrom 2008, 19, 569–585the rabbit aorta. Recent studies have shown that THETAs
relax rabbit small mesenteric arteries [31]. 11,12,15-
THETA mediates acetylcholine-induced relaxations by
activating apamin-sensitive potassium (K) channels in
vascular smooth muscle to induce K efflux, membrane
hyperpolarization, and vascular relaxation [27, 28], while
11,14,15-THETA is not vasoactive [28, 29]. These studies
cogently indicate that biological function is dependent
upon the position of the hydroxyl groups.
Previous studies showed that HETEs and DHETs
form characteristic fragments during MS2 analysis by
ion trap and triple quadrupole mass spectrometers
[32–40]. The mechanisms for electrospray ionization
and tandem mass spectrometry of various classes of
eicosanoids have been elegantly reviewed [41]. In this
study, we investigated the mass spectrometric charac-
teristics of HETEs, DHETs, and THETAs by ESI-FTICR
using SORI-CID and IRMPD. The effects of the number
and the positions of the hydroxyl substituents on frag-
mentation patterns were characterized, and the identi-
ties of THETAs in biological samples were determined.
Experimental
Materials and Methods
11-, 12-, and 15-HETE; 11,12- and 14,15-DHET; 14,15-
EET, and arachidonoyl dopamine were purchased from
Cayman Chemical Co. (Ann Arbor, MI). 11,12,15-,
11,14,15-, and 13,14,15-THETA were synthesized in the
laboratory of Dr. J. R. Falck [42]. Indomethacin, A23187,
and L-ascorbic acid were purchased from Sigma (St.
Louis, MO). C18 Bond Elut solid-phase extraction (SPE)
columns were purchased from Varian (Harbor City,
Figure 1. Structures of HETEs (11-HETE, 1
14,15-DHET), and THETAs (11,12,15-THETA, 11,14,1CA). Acetonitrile was HPLC grade. Distilled, deionized
water was used in all experiments.
Biological Sample Preparation
Tissue preparation and incubation. Aortas were isolated
from 1- to 2-week old New Zealand White rabbits
(Kuiper Rabbit Ranch, Gary, IN), placed in ice-cold
HEPES buffer (in mM; 10 HEPES, 150 NaCl, 5 KCl, 2
CaCl2, 1 MgCl2, and 6 glucose; pH 7.4), cleaned of
adhering connective tissue and fat, and cut into rings
(5-mm long). Aortic rings were incubated for 10 min at
37 °C in HEPES buffer containing indomethacin (105 M).
AA (104 M) was added, and the vessels were incubated
for an additional 5 min. Calcium ionophore A23187 (2 
105 M) was added, and the vessels were incubated for
another 15 min. The reaction was stopped by the addition
of ethanol to a final concentration of 15%. The incubation
buffer was removed, acidified (pH  3.5) with glacial
acetic acid, and extracted on Bond Elut C-18 extraction
columns as previously described [27–29]. The extracts
were evaporated to dryness under a stream of N2 and
stored at 40 °C until further HPLC separation.
Separation of AA metabolites by HPLC. The extracted
samples were first separated into fractions of metabolite
groups by reverse-phase HPLC (Nucleosil-C18 column,
5 m, 4.6  250 mm) using water:acetonitrile mobile
phase containing 0.1% glacial acetic acid. The program
was a 40-min linear gradient from 50% acetonitrile in
water to 100% acetonitrile [28]. The fractions (0.2 mL
per fraction) corresponding to the THETAs (fractions
27–35; 5–7.5 min) were collected and extracted with
TE and 15-HETE), DHETs (11,12-DHET and2-HE
5-THETA and 13,14,15-THETA).
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under a stream of N2 and redissolved in the HPLC
mobile phase. The THETA fraction was rechromato-
graphed on reverse-phase HPLC using water:acetonitrile
(containing 0.1% glacial acetic acid) mobile phase. The
program consisted of a 5-min isocratic phase with 35%
acetonitrile in water, followed by a 35-min linear gradient
to 85% acetonitrile [28]. The fractions that contained the
THETAs (fractions 87–93; 17.5–18.5 min) were collected,
acidified with acetic acid, and extracted with a 50:50
cyclohexane:ethyl acetate. The samples were dried under
a stream of N2 and analyzed by LC-FTICR.
Fourier Transform Ion Cyclotron Resonance
Mass Spectrometry
For the standards, the experiments were performed on
a 7.0 tesla FTICR (IonSpec, Lake Forest, CA) with a
Figure 2. MS/MS spectra of [M  H], m/z 31
SORI-CID and IRMPD FTICR. (a) MS/MS spect
of 11-HETE by IRMPD; (c) MS/MS spectrum
12-HETE by IRMPD; (e) MS/MS spectrum of 15-H
by IRMPD.Z-spray ESI source (Waters Corporation, Milford, MA)
and a Model 22 syringe pump (Harvard, Holliston, MA)
or a high-performance liquid chromatograph (HPLC,
Agilent 1100 series, Palo Alto, CA). Standards were
diluted in 50% acetonitrile:water solution. The stan-
dards were either directly infused by the syringe pump
at a rate of 3 L/min or introduced by flow injection (1
L) through HPLC (Agilent 1100 series, Palo Alto, CA)
into the electrospray source. FTICR was externally
calibrated using 14,15-EET, L-ascorbic acid, and arachi-
donoyl dopamine. Although FTICR can detect HETEs
and DHETs at 5 pg and THETAs at 15 pg, the MS/MS
spectra were measured with HETEs and DHETs at 100
pg and THETAs at 500 pg. These concentrations were
used to assure that the low abundant ions have ade-
quate signals and they were accurately measured. Mass
spectra were acquired in negative mode with ESI probe
and source temperature of 80 °C. The sample cone
HETEs (100 pg) obtained from negative ion ESI
f 11-HETE by SORI-CID; (b) MS/MS spectrum
-HETE by SORI-CID; (d) MS/MS spectrum of
by SORI-CID; (f) MS/MS spectrum of 15-HETE9 for
rum o
of 12
ETE
.2
572 CUI ET AL. J Am Soc Mass Spectrom 2008, 19, 569–585voltage was 45 V, the extractor cone was 10 V, Q1/Q2
RF was 70 V, and arbitrary waveform amplitude was
125 V. The probe high voltage was 3500 V. Transient
signals were collected with 1024 K data points, an
Figure 3. MS/MS spectra of [MH], m/z 337
and IRMPD FTICR. (a) MS/MS spectrum of 1
11,12-DHET by IRMPD; (c) MS/MS spectrum o
Table 1. High-resolution accurate mass measurements by SORI
Measured ions (m/z) Calculated ions (m/z) Error (
11-HETE
319.22872 319.22787 2
301.21788 301.21730 1
275.23886 275.23804 3
257.22796 257.22747 1
207.17625 207.17544 3
167.10801 167.10775 1
149.09752 149.09719 2
123.11851 123.11792 4
12-HETE
319.22722 319.22787 2
301.21653 301.21730 2
257.22674 257.22747 2
179.10724 179.10775 2
163.11239 163.11284 2
135.11756 135.11792 2
15-HETE
319.22738 319.22787 1
301.21563 301.21730 5
257.22673 257.22747 2
219.13863 219.13905 1
175.14887 175.14922 2
113.09705 113.09719 114,15-DHET by IRMPD.analog-to-digital converter (ADC) rate of 4 MHz, and
the transient length of 65.5 ms. The detection range was
set at m/z 54-500. Nitrogen was used as the collision gas
and cooling gas. The precursor ions were isolated in
HETs obtained from negative ion ESI SORI-CID
DHET by SORI-CID; (b) MS/MS spectrum of
5-DHET by SORI-CID; (d) MS/MS spectrum of
FTICR for HETEs
) Relative abundance (%) Elemental composition
17.83 C20H31O3
1
77.16 C20H29O2
1
42.94 C19H31O
1
100.00 C19H29
1
4.95 C14H23O
1
52.71 C10H15O2
1
22.75 C10H13O
1
6.43 C9H15
1
23.16 C20H31O3
1
26.61 C20H29O2
1
100.00 C19H29
1
48.37 C11H15O2
1
43.48 C11H15O
1
63.85 C10H15
1
42.76 C20H31O3
1
17.34 C20H29O2
1
100.00 C19H29
1
15.96 C14H19O2
1
48.96 C13H19
1
20.82 C7H13O
1for D
1,12-
f 14,1-CID
ppm
.7
.9
.0
.9
.9
.6
.2
.8
.0
.6
.8
.8
.8
.7
.5
.5
.9
.9
.0
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SORI-CID was initiated by opening a pulsed valve to
admit a SORI burst with a length of 300 ms, offset
frequency of 4563 Hz, amplitude of 15.5 V, and gas
pulse of 15 ms. IRMPD was conducted with a 75 W
continuous wave CO2 laser at 95% power pulse, length
of 300 ms, and gas pulse of 5 ms. Omega (version
8.0.201, IonSpec) software was used to control the
instrument and analyze the data.
LC-FTICR Analysis of THETAs
LC-FTICR was performed with a 7.0 tesla FTICR cou-
pled to an Agilent 1100 series liquid chromatograph.
Both THETA standards and THETA fractions were
analyzed by LC-FTICR. The THETA standards were
diluted in acetonitrile (1000 pg/L), and the THETA
sample fraction was dissolved in 50 L of acetonitrile.
All HPLC separations were performed at ambient tem-
perature. The samples were analyzed on a reverse-
phase C18 column (Kromasil 1.0  150 mm 5 m;
Varian) using water:acetonitrile containing 0.005% ace-
tic acid as a mobile phase at a flow rate of 100 L/min.
The injection volume was 1 L. The mobile phase
gradient started at 20% acetonitrile in water, and lin-
early increased to 44% acetonitrile over 40 min, and
then linear increased to 100% in 5 min. After 25 min of
run time on the LC, the FTICR was turned on to acquire
data. The FTICR conditions were the same as described
above for the standards.
Table 2. High-resolution accurate mass measurements by SORI
Measured ions (m/z) Calculated ions (m/z) Error (
11.12-DHET
337.23729 337.23843 3
319.22748 319.22787 1
301.21718 301.21730 0
275.23789 275.23804 0
257.22634 257.22747 4
207.17419 207.17544 6
197.11742 197.11832 4
179.10725 179.10775 2
169.12278 169.12340 3
167.10714 167.10775 3
163.11235 163.11284 3
135.11769 135.11792 1
14, 15-DHET
337.23868 337.23843 0
319.22762 319.22787 0
301.21849 301.21730 4
275.23750 275.23804 2
257.22729 257.22747 0
219.13885 219.13905 0
207.13931 207.13905 1
175.14975 175.14922 3
167.10810 167.10775 2
163.14947 163.14922 1
129.09250 129.09210 3.1Results and Discussion
The structures of three HETEs, two DHETs, and three
THETAs are shown in Figure 1. Mass spectra of these
eicosanoids exhibited carboxylate molecular ions [M 
H] with m/z 319 for HETEs, m/z 337 for DHETs, and m/z
353 for THETAs as the most abundant ions. For MS/MS
experiments, the molecular ions were isolated, accelerated
toward the ICR cell, and dissociated. Some similar frag-
mentation patterns of HETEs, DHETs, and THETAs were
observed, indicating the common backbone structures
among these compounds. However, there were unique
fragmentations reflecting the structural characteristics that
can be used to identify these compounds.
Common Fragmentation Pathways for HETEs,
DHETs, and THETAs
MS/MS spectra of all compounds indicated losses of
H2O and CO2 to form a series of ions. For HETEs
(Figure 2 and Table 1), which consist of one hydroxyl
group, m/z 301 corresponding to [M  H  H2O]
, was
observed in all SORI-CID and IRMPD spectra. The m/z
257 was formed by a loss of CO2 from [MHH2O]
.
DHETs with two hydroxyl groups, as shown in Figure
3 and Table 2, the molecular ions (m/z 337) lost two H2O
molecules one after another, to form m/z 319 and 301,
assigned as [M  H  H2O]
 and [ H  2H2O]
,
respectively. These ions could further lose CO2 to form
[M  H  H2O  CO2]
 (m/z 275) and [M  H 
2H2O  CO2]
 (m/z 257), respectively. The loss of H2O
and CO2 are the major fragmentation pathways for
FTICR for DHETs
) Relative abundance (%) Elemental composition
20.04 C20H33O4
1
22.90 C20H31O3
1
27.63 C20H29O2
1
15.95 C19H31O
1
70.41 C19H29
1
9.09 C14H23O
1
19.08 C11H17O3
1
30.77 C11H15O2
1
28.75 C10H17O2
1
100.00 C10H15O2
1
75.87 C11H15O
1
36.80 C10H15
1
38.89 C20H33O4
1
54.05 C20H31O3
1
42.51 C20H29O2
1
19.18 C19H31O
1
98.43 C19H29
1
38.19 C14H19O2
1
100.00 C13H19O2
1
40.49 C13H19
1
8.12 C10H15O2
1
76.78 C12H19
1
1-CID
ppm
.4
.2
.4
.5
.4
.0
.6
.8
.7
.7
.0
.7
.7
.8
.0
.0
.7
.9
.3
.0
.1
.5
92.71 C7H13O2
574 CUI ET AL. J Am Soc Mass Spectrom 2008, 19, 569–585Figure 4. MS/MS spectra of [M  H], m/z 353 for THETAs obtained from negative ion ESI
SORI-CID and IRMPD FTICR. (a) MS/MS spectrum of 11,12,15-THETA by SORI-CID; (b) MS/MS
spectrum of 11,12,15-THETA by IRMPD; (c) MS/MS spectrum of 11,14,15-THETA by SORI-CID; (d)
MS/MS spectrum of 11,14,15-THETA by IRMPD; (e) MS/MS spectrum of 13,14,15-THETA by
SORI-CID; (f) MS/MS spectrum of 13,14,15-THETA by IRMPD.Table 3. High-resolution accurate mass measurements by SORI-CID FTICR for 11, 12, 15-THETA
Measured ions (m/z) Calculated ions (m/z) Error (ppm) Relative abundance (%) Elemental composition
353.23453 353.23335 3.3 25.57 C20H33O5
1
335.22580 335.22278 8.9 4.53 C20H31O4
1
317.21342 317.21222 3.8 10.20 C20H29O3
1
299.20257 299.20165 3.1 9.90 C20H27O2
1
273.22319 273.22239 2.9 13.59 C19H29O
1
255.21169 255.21182 0.5 3.26 C19H27
1
235.13449 235.13397 2.2 12.17 C14H19O3
1
207.13941 207.13905 1.7 25.31 C13H19O2
1
197.11865 197.11832 1.7 100.00 C11H17O3
1
167.10802 167.10775 1.6 39.96 C10H15O2
1
157.12358 157.12340 1.1 38.32 C9H17O2
1
153.12883 153.12849 2.2 14.43 C10H17O
1
1139.11300 139.11284 1.2 30.20 C9H15O
.2
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spectra of m/z 353 of THETAs (Figure 4 and Tables 3, 4,
and 5), which have three hydroxyl groups, the [M 
H] ions easily lost one to three H2O molecules to give
[M  H  H2O]
 (m/z 335), [M  H  2H2O]
 (m/z
317), and [M  H  3H2O]
 (m/z 299). After the losses
of 2 or 3 H2O, [MH 2H2O]
 and [MH 3H2O]

could further dissociate to form [M  H  2H2O 
CO2]
 (m/z 273) and [M  H  3H2O  CO2]
 (m/z
255), respectively.
Compared with HETEs and DHETs, the relative
intensities of these ions (loss of H2O and CO2) in
THETAs were lower than in HETEs and DHETs. The
results suggest that the carbon–carbon bond ruptures
became the major fragments of THETAs. In the com-
parison of three THETAs, the relative intensities of ions
corresponding to the losses of H2O and CO2 for
13,14,15-THETA were slightly higher than for 11,14,15-
and 11,12,15-THETA, suggesting that the positions of
hydroxyl groups affected the losses of H2O and CO2
from the molecular ions. When three hydroxyl groups
were adjacent, as with 13,14,15-THETA, it was easier to
lose H2O or CO2.
Table 4. High-resolution accurate mass measurements by SORI
Measured ions (m/z) Calculated ions (m/z) Error (
353.23520 353.23335 5
335.22255 335.22278 0
317.21416 317.21222 6
299.20354 299.20165 6
273.22405 273.22239 6
255.21371 255.21182 7
235.13527 235.13397 5
223.13530 223.13397 6
205.12465 205.12340 6
167.10833 167.10775 3
85.02952 85.02950 0
Table 5. High-resolution accurate mass measurements by SORI
Measured ions (m/z) Calculated ions (m/z) Error (
353.23454 353.23335 3.
335.22447 335.22278 5.
317.21399 317.21222 5.
299.20348 299.20165 6.
273.22435 273.22239 7.
255.21344 255.21182 6.
253.14608 253.14453 6.
235.13524 235.13397 5.
223.13486 223.13397 4.
217.12449 217.12340 5.
205.12447 205.12340 5.
193.12430 193.12340 4.
173.13440 173.13357 4.
161.13442 161.13357 5.
149.13423 149.13357 4.
129.09271 129.09210 4.
59.01395 59.01385 1.7Unique Fragmentation Pathways for HETEs,
DHETs, and THETAs
Besides the similarities of fragmentation, there were
significant differences in fragmentations among HETEs,
DHETs, and THETAs obtained from SORI-CID and
IRMPD that indicated the characteristics of the molec-
ular structures.
(a) MS/MS Characteristics of HETEs by SORI-CID
and IRMPD.
(1) SORI-CID of HETEs. Figure 2a, c, and e show the
MS/MS spectra obtained from SORI-CID FTICR for 11-,
12-, and 15-HETE, respectively. In the SORI-CID spec-
trum of [M  H] for 11-HETE, the major characteristic
product ions were m/z 167 and 149. The characteristic
m/z 167 is similar to that reported fragmentation by
triple quadrupole and ion trap mass spectrometers
[33, 39, 41]. The MS/MS spectra for 11-HETE by a triple
quadrupole mass spectrometer had the dominant ion of
m/z 167 [33], while spectra from FTICR and ion trap [39]
contained other characteristic ions. The mechanism for
formation of m/z 167 was previously described [41] as
the charge-remote formation of the aldehyde by proton
FTICR for 11, 14, 15-THETA
) Relative abundance (%) Elemental composition
26.34 C20H33O5
1
1.71 C20H31O4
1
9.01 C20H29O3
1
4.44 C20H27O2
1
9.48 C19H29O
1
1.89 C19H27
1
15.85 C14H29O3
1
7.50 C13H19O3
1
19.90 C13H17O2
1
100.00 C10H15O2
1
30.47 C4H5O2
1
FTICR for 13, 14, 15-THETA
) Relative abundance (%) Elemental composition
9.16 C20H33O5
1
29.95 C20H31O4
1
36.52 C20H29O3
1
21.78 C20H27O2
1
15.69 C19H29O
1
20.02 C19H27
1
20.85 C14H21O4
1
23.23 C14H19O3
1
14.73 C13H19O3
1
33.61 C14H17O2
1
50.50 C13H17O2
1
100.00 C12H17O2
1
52.43 C13H17
1
25.51 C12H17
1
41.29 C11H17
1
24.04 C7H13O2
1
1-CID
ppm
.2
.7
.1
.3
.1
.4
.5
.0
.1
.5-CID
ppm
4
0
6
1
2
3
1
4
0
0
2
7
8
3
4
749.36 C2H3O2
TE.
576 CUI ET AL. J Am Soc Mass Spectrom 2008, 19, 569–585transfer and the cleavage of the C10-C11 bond. Another
characteristic ion of the m/z 149 was observed and
proposed as a cleavage of the C11-C12 bond and a loss
of CO2. Another particular ion with high intensity was
observed at m/z 275. It was formed by a direct loss of
CO2 from the [M  H]
 ion. The losses of CO2 and H2O
by [M  H] ion formed the highest abundant m/z 257,
although these two ions were not detected in the
previous studies [33, 41] (Scheme 1a).
For 12-HETE, the major characteristic ions were m/z
179, 163, and 135 and were similar to the results from
the ion trap mass spectrometer [39]. Again, the m/z 257
is the highest abundant ion. The mechanism for the m/z
179 formation was previously described [41]. We pro-
posed that the negative charge was located at the
carboxylate because the presence of the m/z 135 ion,
corresponding to a loss of CO2 from them/z 179. Them/z
163 was presumably the result of carbon-carbon bond
cleavage from C12-C13 and loss of CO2 (Scheme 1b).
The characteristic product ions of 15-HETE were m/z
Scheme 1. Proposed major fragmentation pa
ESI-FTICR. (a) 11-HETE; (b) 12-HETE; (c) 15-HE219, 175, and 113 and were similar to previous studies[33, 39]. The m/z 219 was the product ion formed by the
identical mechanism as previously described for them/z
179 of 12-HETE [41]. The m/z 175 was the subsequent
loss of CO2 from the m/z 219 (Scheme 1c). The elemental
composition of the m/z 113 indicated the fragment of
C7H13O
1, suggesting the double-bond conjugation and
cleavage of C13–C14 bond. The abundance of this ion
increased in IRMPD (see below).
(2) IRMPD of HETEs. The major product ions gen-
erated from IRMPD were similar to those generated
from SORI-CID, but the relative intensities of these ions
were different. In IRMPD spectra of [M  H] for all
three HETEs (Figure 2b, d, and f), the relative intensity
of m/z 257 decreased, while this ion was the highest
abundant ion in SORI-CID spectra of HETEs. It indi-
cated that the loss of CO2 from the [MHH2O]
 ion
for HETEs became less effective with IRMPD. For
12-HETE (Figure 2d), m/z 179 was the most abundant
ion, indicating that the break of C11-C12 bond was the
major pathway [41]. For 15-HETE (Figure 2f), m/z 219
ys of 11-, 12- and 15-HETE by negative ionthwaand 113 became the major ions. The m/z 219 was formed
thwa
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located on the carboxyl group. The formation of m/z 113
was the result of double-bond conjugation and the
rupture of C13–C14 bond as in SORI-CID.
(b) MS/MS characteristics of DHETs by SORI-CID
and IRMPD.
(1) SORI-CID of DHETs. In the SORI-CID spectrum
of [M  H], m/z 337, for 11,12-DHET is shown in
Scheme 2. Proposed major fragmentation paScheme 3. Proposed major fragmentation pathwaFigure 3a and the ions are shown in Table 2. The
prominent m/z 167, 163, 135, 179, 197, 153, and 169 were
observed and were similar to the results from ion trap
mass spectrometer [39]. Formation of the highest abun-
dant m/z 167 was similar to 11-HETE [41]. If the charge
was relocated on the hydroxyl oxygen at C12, the m/z
169 could be formed by the same fragmentation mech-
anism. The m/z 197 was a result of the cleavage of
ys of 11,12-DHET by negative ion ESI FTICR.ys of 14,15-DHET by negative ion ESI FTICR.
ETA
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to a loss of H2O and CO2 from the m/z 197, respectively.
The m/z 135 was formed by a loss of CO2 from the m/z
179 or a loss of H2O from the m/z 153, respectively. The
m/z 163 was derived from the cleavage of C12–C13 and
the losses of H2O and CO2. The major fragmentation
pathways of 11,12-DHET were proposed in Scheme 2.
The CID spectrum of [M  H], m/z 337, for 14,15-
DHET had several characteristic ions (Table 2) that were
similar to the results from the ion trap mass spectrom-
eter [39] with the most abundant fragments of m/z 207
and 257 (Figure 3c). The m/z 257 was the result of the
loss of 2H2O and CO2 from the [M  H]
 ion. The m/z
207 was derived from the cleavage of the C13-C14 bond
as previously described [39, 41]. In addition to m/z 207,
other major ions were observed at m/z 129, 163, 175, and
219. The m/z 163 was from a loss of CO2 from the m/z
207. If the charge was relocated on the hydroxyl oxygen
at C15, m/z 129 can be formed at high abundance by the
same dissociation as m/z 207. The m/z 219 resulted from
a loss of H2O and the charge-driven cleavage of the
Scheme 4. Proposed mechanism of formation
SORI-CID spectrum of [M  H]– for 11,12,15-THC14–C15 bond from the molecular ion as described for15-HETE above. The subsequent loss of CO2 by m/z 219
formed m/z 175 with high abundance. Some other low
abundant ions were also observed in the spectra, such
as m/z 127 derived from cleavage at the C7–C8 bond,
m/z 167 derived from the cleavage at the C10–C11 bond.
Scheme 3 illustrates the proposed dissociation reactions
of 14,15-DHET.
(2) IRMPD of DHETs. The IRMPD spectra of [M 
H] for DHETs were similar to those formed by SORI-
CID, indicating the same major fragmentation patterns.
In the IRMPD spectra of [M  H] for 11,12- and
14,15-DHETs (Figure 3b and d), the intensity of m/z 257
also decreased similar to HETEs as described above.
The intensities of m/z 319 and 301, which were the
results of the loss of one and two H2O from the
molecular ions, became higher, indicating easy losses of
H2O to produce [M  H  H2O]
 and [M  H 
2H2O]
. Interestingly, the m/z 163 instead of m/z 167
was observed as the high abundant ion for 11,12-DHET
(Figure 3b) similar to 12-HETE. The results suggested
that 11,12-DHET possibly lost H2O at the C11 position
the m/z 197 and m/z 157 in the negative ion
.ofand fragmented with the mechanism similar to 12-
ys of
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low m/z range of the IRMPD spectrum of 11,12-DHET,
such as m/z 58, 123, 113, 177, and 139, indicating further
fragmentation from excessive energy. For 14,15-DHET,
the intensities of m/z 175, 163, and 129 became lower in
the IRMPD spectrum with the m/z 207 as the highest
Scheme 5. Proposed fragmentation pathwaScheme 6. Proposed fragmentation pathways ofabundance ion (Figure 3d). This suggested the domi-
nant C13–C14 cleavage.
In general, the major product ions in the CID spectra
of HETEs and DHETs obtained from FTICR were
similar to ions obtained from ion trap and triple quad-
rupole mass spectrometers [34–41]. However, more
11,12,15-THETA by negative ion ESI FTICR.11,14,15-THETA by negative ion ESI FTICR.
y of
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were obtained from FTICR similar to ion trap than
triple quadrupole mass spectrometry. Losses of H2O
and CO2 to form characteristic ions are more favorable
in FTICR. Furthermore, the structures of these frag-
ments can be ascertained based on the corresponding
high-resolution and accurate mass data from FTICR.
For example, the m/z 163 for 12-HETE and 11,12-DHET
has the masses of 163.11,239 and 163.11,235, respec-
tively. This ion has the elemental composition of
C11H15O
1 (Tables 1 and 2). However, the m/z 163 for
14,15-DHET has the mass of 163.14,947 with the elemen-
tal composition of C12H19
1 (Table 2). These results
indicated that the fragmentation mechanisms of the m/z
163 for 12-HETE/11,12-DHET, and 14,15-DHET are
different as shown in Schemes 1, 2, and 3.
(c) MS/MS Characteristics of THETAs by SORI-CID
and IRMPD.
(1) SORI-CID of THETAs. All THETAs exhibited
identical [MH],m/z 353. Figure 4a, c, and e show the
MS/MS spectra obtained from SORI-CID FTICR of
11,12,15-, 11,14,15-, and 13,14,15-THETA, respectively.
Their high-resolution and accurate mass spectrometric
Scheme 7. Proposed fragmentation pathwadata and corresponding predicted elemental composi-tion of their fragments are shown in Tables 3, 4, and 5,
respectively. With three hydroxyl groups, the spectra of
THETAs were more complex than spectra of HETEs
and DHETs.
For 11,12,15-THETA, (Figure 4a and Table 3), the
major ions were m/z 197, 167, 157, 139, and 127. The
most abundant product ion was m/z 197. This ion was
the result of the charge-driven cleavage of C11–C12 by
the loss of neutral aldehyde from the enolate anion in
which the charge was relocated on the hydroxyl oxygen
at C12. If the charge was relocated on the hydroxyl
oxygen at C11, the m/z 157 was formed by the similar
fragmentation mechanism as shown in Scheme 4. The
m/z 157 then lost H2O to form m/z 139. The mechanism
for formation of m/z 167 was the same as the ion of
11-HETE [41]. If the charge was relocated on the hy-
droxyl oxygen at C15, the m/z 235 was likely formed by
the losses of H2O and hexyl aldehyde from the cleavage
of C14–C15 bond. Scheme 5 illustrates the proposed
fragmentation pathways for 11,12,15-THETA.
The SORI-CID spectrum of [M  H] for 11,14,15-
THETA (Figure 4c and Table 4) was dominated by the
m/z 167. The formation of the m/z 167 was the result of
13,14,15-THETA by negative ion ESI FTICR.the double-bond conjugation and then, the break of
f (a) 8
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[41]. In addition, the unique characteristic m/z 85 was
observed for 11,14,15-THETA. The elemental composi-
tion of this ion was assigned as C4H5O2
1. The pro-
posed mechanism for its formation was the cleavages of
C10–C11 bond and C14–C15 bond. Besides the m/z 167
and 85, the m/z 129, 205, 223, and 235 were also
Figure 5. Total ion chromatogram (top panel)
from rabbit aorta by negative ion LC-ESI-FTICR
from negative ion ESI FTICR at detection time oobserved for 11,14,15-THETA. The proposed fragmen-tation pathways for these ions were similar to DHETs as
shown in Scheme 6.
When 11,12,15- and 11,14,15-THETA were com-
pared, 11,12,15-THETA needed more collisional energy
to fragment than 11,14,15-THETA. The different posi-
tions of the second hydroxyl group and the third
double-bond in the structures of 11,12,15-THETA and
product ion mass spectra of THETAs isolated
IRMPD. MS/MS spectrum of m/z 353 obtained
.93 min; (b) 9.28 min; (c) 9.46 min; (d) 9.64 min.and
with11,14,15-THETA resulted in a remarkable and diagnos-
582 CUI ET AL. J Am Soc Mass Spectrom 2008, 19, 569–585tically useful difference in their major fragmentation
pathways. The m/z 197, 207, 157, and 139 were the
characteristic product ions with m/z 197 as the highest
abundant ion for 11,12,15-THETA. Them/z 167, 205, and
85 were the characteristic product ions with m/z 167 as
the most abundant ion for 11,14,15-THETA.
Figure 4e and Table 5 show the SORI CID spectrum
and fragments of [M  H] for 13,14,15-THETA. The
m/z 193 was observed as the most abundant ion, which
was proposed to form by the double-bond conjugation
and the break of C12–C13 bond similar to the formation
of m/z 179 for 12-HETE [41]. This ion then lost CO2 to
form the m/z 149. Other product ions were m/z 253, 235,
223, 217, 205, 173, 161, and 129. If the charge was
relocated at C15 oxygen group, the m/z 253 was formed
by the charge-driven loss of neutral aldehyde from
C14–C15 bond. The m/z 235, 217, and 173 were formed
by the losses of H2O or CO2 from m/z 253. The m/z 223
and 129 were formed by breaking of the C13–C14 bond.
The former ion lost H2O to form the m/z 205, and then
lost CO2 to produce the m/z 161. The unique character-
istic m/z 59 was observed for 13,14,15-THETA. The
proposed formation of this ion was the cleavage of
C12–C13 bond and C14–C15 bond similar to the m/z 85
for 11,14,15-THETA. The proposed fragmentation path-
ways for 13,14,15-THETA are shown in Scheme 7.
(2) IRMPD of THETAs. Figure 4b, d, and f show the
product ion spectra obtained from IRMPD of 11,12,15-,
11,14,15-, and 13,14,15-THETA, respectively. The major
product ions obtained from IRMPD were similar to
SORI-CID, suggesting similar major fragmentation
pathways of THETAs. However, there were some dif-
ferences between SORI-CID and IRMPD spectra. For
11,14,15-THETA (Figure 4d), the intensities of the m/z
205 in the IRMPD spectrum increased 2-fold, and the
abundance of m/z 85 decreased, compared with SORI-
CID. IRMPD favored the m/z 205 by the cleavage of
neutral aldehyde from C13–C14 bond and the subse-
quent loss of H2O. This may be due to the product ion
obtaining more energy from the laser, and then frag-
mentation to generate higher abundant m/z 205. For
Table 6. High-resolution accurate mass measurements by
IRMPD FTICR for biological samples
Measured ions
(m/z)
Calculated ions
(m/z)
Error
(ppm)
Elemental
composition
353.23141 353.23335 5.5 C20H33O5
1
317.21112 317.21222 3.5 C20H29O3
1
299.20090 299.20165 2.5 C20H27O2
1
273.22148 273.22239 3.5 C19H29O
1
235.13307 235.13397 3.8 C14H19O3
1
207.13821 207.13905 4.1 C13H19O2
1
205.12257 205.12340 4.0 C13H17O2
1
197.11747 197.11832 4.3 C11H17O3
1
167.10673 167.10775 6.1 C10H15O2
1
157.12265 157.12340 4.8 C9H17O2
1
139.11211 139.11284 5.2 C9H15O
1
85.02898 85.02950 6.1 C4H5O2
111,12,15-THETA, the relative abundance of the m/z 207increased with IRMPD. However, the abundance of the
other product ions, such as m/z 157, 167, 177, 139, and
127, decreased. For 13,14,15-THETA, there were obvi-
ous differences between IRMPD and SORI-CID. The
abundance of the m/z 59 and 173 decreased ten-fold in
the IRMPD spectrum, and the other ions such as m/z
205, 149, 129, 217, 235, and 253 also decreased. These
two techniques complemented each other, providing
more useful structural information.
Identification of THETAs as Arachidonic Acid
Metabolites in Rabbit Aorta Samples
The THETA fraction in rabbit aorta samples was ana-
lyzed by negative ion LC-FTICR to obtain structural
information for identification of THETA isomers. The
mass spectrum of the samples showed the most abun-
dant ion of m/z 353 ([M  H]). The molecular weight
was determined as 354 Da with the elemental compo-
sition of C20H34O5.
Figure 5 (top panel) shows the total ion chromatogram
of the MS/MS of m/z 353 by IRMPD. Figure 5a, b, c, and
d show the product ions of m/z 353 obtained from differ-
ent retention times by IRMPD. The m/z 335, 317, and 299
were observed, suggesting the subsequent losses of one to
three H2O from [MH]
. These ions indicated three OH
groups were present in the structures. The low abundance
of these ions also suggested that the positions of three OH
groupswere not adjacent. The changes in spectral patterns
at different retention times (from a to d) suggested that the
peak contained more than one compound. A complete
separation of THETA regioisomers on a reverse phase LC
column was not obtained.
These mass spectra revealed the presence of char-
acteristic products, m/z 85, 167, 205, 197, 157, 139, and
207, which belonged to THETAs (Table 6). The m/z
167, 205, and 85 were the characteristics of 11,14,15-
THETA, and the m/z 197, 157, 139, and 207 were the
characteristics of 11,12,15-THETA. As shown in Fig-
ure 5a, the characteristics of 11,14,15-THETA, such as
m/z 167, 205, and 85, were observed, but no m/z 197,
157, 139, and 207 were observed, suggesting that
11,14,15-THETA eluted first. With a longer eluting
time (as shown in Figure 5b, c, and d), the m/z 197,
157, 139, and 207 appeared and the intensities of these
ions increased, suggesting that 11,12,15-THETA
eluted after 11,14,15-THETA.
Figure 6 shows the total ion chromatograms (top
panel by IRMPD) and the selected ion chromatograms
of m/z 85, 139, 157, 167, 197, 205, and 207 by both
SORI-CID and IRMPD. The m/z 167, the major ion for
11,14,15-THETA and the minor ion for 11,12,15-THETA,
exhibited a broad peak. According to the different
retention times of these ions (run time of 25.00 min 
detection time), the ions could be divided into two
groups; a group of m/z 167, 205, and 85 (Figure 6c, e, g,
and d, f, h) with identical detection times (9.44 min),
suggesting that they were generated from one com-
pound, 11,14,15-THETA, and another group of m/z
583J Am Soc Mass Spectrom 2008, 19, 569–585 IDENTIFICATION OF EICOSANOIDS BY FTICRFigure 6. Total ion chromatograms and selected ion chromatograms of THETA fraction (top panels)
isolated from rabbit aorta by negative ion LC-ESI-FTICR with SORI-CID and IRMPD. Total ion
chromatograms by SORI-CID (a) and IRMPD (b); selected ion chromatogram of m/z 167 by SORI-CID
(c) and IRMPD (d); selected ion chromatogram ofm/z 205 by SORI-CID (e) and IRMPD (f); selected ion
chromatogram of m/z 85 by SORI-CID (g) and IRMPD (h); selected ion chromatogram of m/z 197 by
SORI-CID (i) and IRMPD (j); selected ion chromatogram of m/z 157 by SORI-CID (k) and IRMPD (l);
selected ion chromatogram of m/z 139 by SORI-CID (m) and IRMPD (n); selected ion chromatogram
of m/z 207 by SORI-CID (o) and IRMPD (p). Note: The indicated times were detection times (retention
time  detection time  25 min).
584 CUI ET AL. J Am Soc Mass Spectrom 2008, 19, 569–585197,157, 13,9 and 207 (Figure 6i, k, m, o, and j, l, n, p)
with identical detection times (9.64 min), suggesting
that they were from 11,12,15-THETA (see also Figure
4a, b, c, and d). The m/z 205 also exhibited a small peak
at a longer detection time (10.60 min). This ion is
present in the spectra of both 11,14,15- and 13,14,15-
THETA. However, the peak of the biological sample
at 10.60 min did not have m/z 193 and the retention
time did not match 13,14,15-THETA, suggesting the
possibility of another THETA being present at very
low concentration.
To further confirm the identity of these THETAs, a
mixture of 11,12,15-THETA and 11,14,15-THETA was
analyzed by LC-FTICR using the same conditions as the
biological sample. The retention times and MS/MS
spectra of biological THETAs were identical to the
THETA standards. Comparing to the abundance of
THETA standards, the concentration of THETAs in
biological samples was 800 pg on the column. The
results indicated that both 11,12,15- and 11,14,15-
THETA were produced in the rabbit aorta with
11,14,15-THETA being the major isomer.
Conclusions
Many isomers of low molecular weight, biologically
active compounds such as eicosanoids can be present in
biological samples. LC-MS and LC-MS/MS have been
very successful in the identification and determination
of eicosanoids with less complex molecular structures
such as HETEs and DHETs. However, relatively newer
groups of eicosanoids such as THETAs, which contain
more hydroxyl groups at various positions on the
arachidonic acid backbone, are more challenging.
Chromatographic separation, particularly with re-
verse phase, of these compounds is difficult. Further-
more, the MS/MS fragmentation patterns of these com-
pounds are very complex and not always useful for
stereochemical identification.
Previously, eicosanoids were successfully identified
by GC-MS. The substituents on the eicosanoids such as
hydroxyl groups were typically derivatized to improve
sample volatility. With increasing hydroxyl groups, the
efficiency of chemical derivatization decreased. Thus, if
LC-MS can accomplish the identification without the
need for derivatization, it will be a powerful tool for
these compounds. The SORI-CID and IRMPD in FTICR
provide unique and useful spectral characteristics of
highly substituted eicosanoids such as THETAs. Taking
advantages of FTICR for its high mass resolution and
accuracy, their fragments and molecular structures can
be assigned. As demonstrated here, the regioisomers of
the unresolved mixture of THETAs in biological sam-
ples were identified.
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